Harvard Medical School researchers have developed a new way to find drugs that selectively kill “cancer stem cells” or prevent them from dividing (cancer stem cells are now thought to be capable of generating and maintaining a tumor and are resistant to standard cancer treatments).

The team is currently using the method to identify drug candidates for leukemia, a disease for which cancer stem cells have been well characterized. The researchers believe that the approach could eventually extend to other kinds of cancer.